Patellofemoral arthritis
Conditions
Interventions
Control group:Health education
treatment group:Tuina combined with health education
Sponsors
The Third Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: Diagnostic criteria: 1) Recurrent knee pain in the past month mainly in front of the knee; 2) Age: =50 years old; 3) Morning stiffness time =30 min; 4) There is bone friction sound (feeling) during activity; 5) Radiographs (standing or weight-bearing position) show narrowing of joint space subchondral sclerosis and/or cystic degeneration and osteophyte formation at the joint margin; 6) MRI showed cartilage injury osteophyte formation subchondral bone marrow edema and/or cystic change degenerative tears of meniscus partial or full cartilage loss. Meeting the diagnostic criteria 1+2+3+4 or 1+5 or 1+6 can be diagnosed as knee osteoarthritis. Patients who meet the above diagnostic criteria and have any of the following clinical signs or symptoms can be diagnosed with PFOA. 1) Anterior knee pain mainly patellar edge pain; 2) The patellofemoral joint produces a crepitating or grinding sensation during knee flexion 3) Patella grinding test positive; 4) Squat test positive; 5) Quadriceps resistance test is positive. Inclusion criteria Patients who meet the above diagnostic criteria and meet the following requirements can be included in this study 1) Have known the test requirements and precautions and signed the informed consent; 2) K-L classification: ? ?; 3) Did not receive knee osteoarthritis and patellofemoral arthritis drugs and other treatment in the past month 4) Aged between 50 and 75 (including 50 and 75 years old).
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria should be excluded: 1) Other serious knee joint diseases such as knee joint tuberculosis tumor rheumatism and rheumatoid arthritis patellar dislocation synovitis of knee joint serious cardiovascular disease liver and kidney function injury immune deficiency diabetes gout blood disease skin disease etc. are not limited to patients with PFOA alone; 2) Patients with proximal lesions that affect normal walking due to contusion of lower limb joint foot deformity or pain local trauma of knee joint or other factors; 3) Have mental disorders and mental disorders can not cooperate with the questionnaire investigators; 4) Patients with PFOA and KOA who have been treated with other therapeutic means such as patch or physiotherapy in the past month; 5) Patients who have undergone total knee replacement and patellofemoral joint replacement; 6) Women who are pregnant breastfeeding or have a pregnancy plan within the last six months; 7) patellofemoral arthritis K/L grade 0 3 4 or imaging findings of joint malformation articular cartilage destruction serious; 8) Those who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The maximum strength of flexor and extensor muscles rectus femoris and lateral femoris muscles during flexion and extension of knee joint in sitting position;The pain threshold of the tenderness point of the patella margin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total effective rate;McMaster University of Western Ontario Osteoarthritis Indicator (WOMAC) score;Modified version of 30s sitting and standing experiment; | — |
Countries
China
Contacts
Public ContactCHEN juntao
The Third Affiliated Hospital of Henan University of Chinese Medicine
Outcome results
None listed